WHO ICTRP trial
An open phase II study of safety, tolerability, highest tolerable dose and…
EUCTR2019-003779-20-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2019-003779-20-DE |
|---|---|
| Public title | An open phase II study of safety, tolerability, highest tolerable dose and anti-tumor effect of SCO-101 in combination with FOLFIRI as a safe and effective treatment of patients with widespread colorectal cancer who has developed treatment resistance to treatment with FOLFIRI |
| Scientific title | An?open-label phase II prospective clinical trial to?investigate safety, tolerability, maximum tolerated dose and anti-tumor?effect for SCO-101 in combination with?FOLFIRI?as?a safe and efficient treatment modality?in metastatic or advanced colorectal cancer (mCRC) patients with… |
| Primary sponsor | Scandion Oncology A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain;Denmark;Germany |
| Conditions | Metastatic or advanced colorectal cancer (mCRC) with acquired resistance to chemotherapy? MedDRA version: 21.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area… |
| Interventions | Product Name: SCO-101 Product Code: SCO-101 Pharmaceutical Form: Tablet INN or Proposed INN: SCO-101 CAS Number: 265646-85-3 Current Sponsor code: SCO-101 Other descriptive name: N-[4-bromo-2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]-N'-[3,5… |
| Registration date | Oct 29, 2021 |
| Target size | 35 |
| Secondary IDs | SCO101-001;2019-003779-20-DK |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: